The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
Abstract
OBJECTIVE: Insulin resistance (IR) was reported to be associated with chronic heart failure (CHF). Adiponectin, an insulin-sensitizing hormone with anti-inflammatory activity, improves energy metabolism via AMP-activated protein kinase (AMPK). AMPK deficiency is associated with depressed cardiac function under stress conditions. However, it is not clear whether adiponectin plays an important role in CHF. We hypothesize that deficiency of adiponectin might result in deterioration of heart failure. METHODS: Using adiponectin null mice and their littermates, we examined the effects of adiponectin on LV pressure overload-induced cardiac hypertrophy and failure, and investigated the mechanisms involved. RESULTS: Three weeks after transverse aortic constriction (TAC), cardiac hypertrophy (evaluated from the heart-to-body weight ratio: 7.62+/-0.27 in wild-type (WT) mice, 9.97+/-1.13 in knockout (KO) mice, P<0.05) and pulmonary congestion (lung-to-body weight ratio: 9.05+/-1.49 in WT mice, 14.95+/-2.36 in KO mice, P<0.05) were significantly greater in adiponectin KO mice than WT mice. LV dimensions were also increased in KO mice. Compared with WT TAC mice, expression of AMPKalpha protein was lower, while IR was higher in KO TAC mice. CONCLUSION: These findings indicate that adiponectin deficiency leads to progressive cardiac remodeling in pressure overloaded condition mediated via lowing AMPK signaling and impaired glucose metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the use of adiponectin KO mice, it was shown that adiponectin deficiency enhanced progressive cardiac remodeling induced by surgical aortic constriction (208).”
From Cardiac remodeling in obesity (2008) · cites this paper as [208]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Self-citationMalik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,837
Cited by
Sorted by citations
Items 101–200 of 234
Excess perigestational folic acid exposure induces metabolic dysfunction in post-natal life
Keating, E., Correia‐Branco, A., Araújo, J. R., Meireles, M., Fernandes, R., Guardão, L., Guimarães, J. T., Martel, F., & Calhau, C. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0448 · Cited by 46
Obesity and insulin resistance: Effects on cardiac structure, function, and substrate metabolism
Peterson, L. R. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0022-y · Cited by 44
Liao, Y., Takashima, S., ZHAO, H., ASANO, Y., Shintani, Y., Minamino, T., KIM, J., Fujita, M., HORI, M., & Kitakaze, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.021 · Cited by 45
Self-citationEvidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Li, P., Shibata, R., Unno, K., Shimano, M., Furukawa, M., Ohashi, T., Cheng, X. W., Nagata, K., Ouchi, N., & Murohara, T. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.141655 · Cited by 42
Self-citationOkubo, T., Takemura, N., Yoshida, A., & Sonoyama, K. (2013) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.32.93 · Cited by 43
A high-fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload
Bouchard-Thomassin, A.-A., Lachance, D., Drolet, M., Couët, J., & Arsenault, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00199.2010 · Cited by 43
Inflammatory biomarkers responses after acute whole body vibration in fibromyalgia
Ribeiro, V. G. C., Mendonça, V. A., de Souza, A. L. G., da Fonseca, S. F., Camargos, A. C. R., Lage, V. K. D. S., Neves, C. D. C., dos Santos, J. M., Teixeira, L. A. C., Vieira, É. L. M., et al. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176775 · Cited by 42
Patel, J. V., Abraheem, A., Dotsenko, O., Creamer, J., Gunning, M., Hughes, E. A., & Lip, G. Y. H. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02007.x · Cited by 41
AMP-Activated Protein Kinase (AMPK)-Dependent Regulation of Renal Transport
Glosse, P., & Föller, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113481 · Cited by 41
Adipocytokines in Cardiovascular and Metabolic Diseases
Ouchi, N. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34918 · Cited by 39
Self-citationAdiponectin ameliorates hypoxia-induced pulmonary arterial remodeling
Nakagawa, Y., Kishida, K., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.004 · Cited by 37
Self-citationCharacterization of a robust mouse model of heart failure with preserved ejection fraction
Matsiukevich, D., Kovács, A. D., Li, T., Kokkonen-Simon, K. M., Matkovich, S. J., Oladipupo, S. S., & Ornitz, D. M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00038.2023 · Cited by 39
Xu, Q., Lekgabe, E. D., Gao, X., Ming, Z., Tregear, G. W., Dart, A. M., Bathgate, R. A. D., Samuel, C. S., & Du, X. (2007) · Endocrinology · doi:10.1210/en.2007-1220 · Cited by 37
Huang, K., Liang, Y., Ma, Y., Wu, J., Luo, H., & Yi, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.774272 · Cited by 43
Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle
Bugianesi, E. (2007) · Hepatology · doi:10.1002/hep.22105 · Cited by 36
Jahng, J. W. S., Turdi, S., Kovacevic, V., Dadson, K., Li, R., & Sweeney, G. (2015) · Endocrinology · doi:10.1210/en.2015-1162 · Cited by 35
Left Ventricular Diastolic Dysfunction in Diabetic Patients
Tsujino, T., Kawasaki, D., & Masuyama, T. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00002 · Cited by 34
Kobara, M., Furumori, A., Kitamura, M., Matsumura, M., Ohigashi, M., Toba, H., & Nakata, T. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.016 · Cited by 33
Targeting adiponectin for cardioprotection
Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.573 · Cited by 33
Self-citationShimano, M., Inden, Y., Tsuji, Y., Kamiya, H., Uchikawa, T., Shibata, R., & Murohara, T. (2008) · EP Europace · doi:10.1093/europace/eun140 · Cited by 33
O’Shea, K. M., Chess, D. J., Khairallah, R. J., Rastogi, S., Hecker, P. A., Sabbah, H. N., Walsh, K. X., & Stanley, W. C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00957.2009 · Cited by 31
Clain, J., Couret, D., Planesse, C., Trotot, P. K., Meilhac, O., d’Hellencourt, C. L., Viranaïcken, W., & Diotel, N. (2022) · Brain Sciences · doi:10.3390/brainsci12050680 · Cited by 32
Adiponectin Levels Are Elevated in Patients With Pulmonary Arterial Hypertension
Santos, M., Reis, A., Gonçalves, F., Ferreira‐Pinto, M. J., Cabral, S., Torres, S., Leite-Moreira, A. F., & Henriques‐Coelho, T. (2013) · Clinical Cardiology · doi:10.1002/clc.22210 · Cited by 29
Huang, S., Huang, P., Chen, Y., Chiang, K., Chen, J., & Lin, S. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3533 · Cited by 30
Bin-Jumah, M. N. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6290143 · Cited by 30
AMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy
Konhilas, Y. L. J. P. (2015) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000154 · Cited by 28
Ohara, T., Kim, J., Asakura, M., Asanuma, H., Nakatani, S., Hashimura, K., Kanzaki, H., Funahashi, T., Tomoike, H., & Kitakaze, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.825 · Cited by 29
Self-citationImpact of Oxidative Stress on Plasma Adiponectin in Patients With Chronic Heart Failure
Tanaka, T., Tsutamoto, T., Nishiyama, K., Sakai, H., Fujii, M., Yamamoto, T., & Horie, M. (2007) · Circulation Journal · doi:10.1253/circj.72.563 · Cited by 28
Central Adiposity or Hypertension
Packer, M., Butler, J., Lam, C. S. P., Zannad, F. M., Vaduganathan, M., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.036 · Cited by 30
Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase
Dong, S., Baranwal, S., García, A., Serrano-Gomez, S. J., Eastlack, S. C., Iwakuma, T., Mercante, D. E., Mauvais‐Jarvis, F., & Alahari, S. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784256 · Cited by 25
Guo, Z., Zheng, C., Qin, Z., & Wei, P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01157.x · Cited by 25
Jong, K. A. D., Barrand, S., Wood‐Bradley, R. J., Almeida, D. L., Czeczor, J. K., Lopaschuk, G. D., Armitage, J. A., & McGee, S. L. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.019 · Cited by 26
Chen, C., Asakura, M., Asanuma, H., Hasegawa, T., Tanaka, J., Toh, N., Min, K.-D., Kanzaki, H., Takahama, H., Amaki, M., et al. (2012) · Hypertension Research · doi:10.1038/hr.2012.42 · Cited by 23
Self-citationGuo, Z., Qin, Z., Zhang, R., Li, J., & Yin, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.010 · Cited by 24
Niemann, B., Pan, R., Teschner, M., Boening, A., Silber, R., & Rohrbach, S. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.04.005 · Cited by 24
Pang, T., Rajapurohitam, V., Cook, M. A., & Karmazyn, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00424.2009 · Cited by 24
Adiponectin in the Heart and Vascular System
Ding, M., Rzucidlo, E. M., Davey, J. C., Xie, Y., Liu, R., Jin, Y., Stavola, L. K., & Martin, K. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00011-7 · Cited by 21
O’Shea, K. M., Chess, D. J., Khairallah, R. J., Hecker, P. A., Lei, B., Walsh, K. X., Rosiers, C. D., & Stanley, W. C. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-95 · Cited by 20
Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure
Ohara, T., Hashimura, K., Asakura, M., Ogai, A., Amaki, M., Hasegawa, T., Kanzaki, H., Sonoda, M., Nishizawa, H., Funahashi, T., et al. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.06.010 · Cited by 20
Self-citationGuo, Z., Qi, W., Yu, Y.-X., Du, S., Wu, J., & Liu, J. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-29 · Cited by 20
Pierard, M., Conotte, S., Tassin, A., Boutry, S., Uzureau, P., Boudjeltia, K. Z., & Legrand, A. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0138-2 · Cited by 21
Jeon, Y. H., He, M., Austin, J., Shin, H., Pfleger, J. M., & Abdellatif, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109866 · Cited by 20
Dadson, K., Turdi, S., Boo, S., Hinz, B., & Sweeney, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121049 · Cited by 19
Çavuşoğlu, E., Chopra, V., Battala, V. R., Ruwende, C., Yanamadala, S., Eng, C., Pinsky, D. J., & Marmur, J. D. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.12.008 · Cited by 18
Impact of heart-specific disruption of the circadian clock on systemic glucose metabolism in mice
Nakao, T., Kohsaka, A., Otsuka, T., Thein, Z. L., Le, H. T., Waki, H., Gouraud, S. S., Ihara, H., Nakanishi, M., Sato, F., et al. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1415922 · Cited by 17
Brar, P. C., Chun, A., Fan, X., Jani, V., Craft, M., Bhatla, P., & Kutty, S. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0976-0 · Cited by 19
Role of adipose tissue in the development of vascular complications in type 2 diabetes mellitus
Kowalska, I. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.007 · Cited by 17
Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion
Fujishima, Y., Maeda, N., Matsuda, K., Komura, N., Hirata, A., Mori, T., Sekimoto, R., Tsushima, Y., Nishizawa, H., Funahashi, T., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.043 · Cited by 17
Self-citationGrilo, L. F., Diniz, M. S., Tocantins, C., Areia, A. L., & Pereira, S. P. (2022) · Obesities · doi:10.3390/obesities2030019 · Cited by 16
The evolving role of adiponectin as an additive biomarker in HFrEF
Sente, T., Gevaert, A. B., Berendoncks, A. V., Vrints, C. J., & Hoymans, V. Y. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9578-z · Cited by 16
Fat, fire and muscle – The role of adiponectin in pulmonary vascular inflammation and remodeling
Medoff, B. D. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.06.006 · Cited by 16
Hiwasa, T., Zhang, X., Kimura, R., Ohno, M., Chen, P., Nishi, E., Ono, K., Kimura, T., Kamitsukasa, I., Wada, T., et al. (2016) · Journal of Circulating Biomarkers · doi:10.5772/63218 · Cited by 15
Rosiak, M., Postula, M. A., Kapłon‐Cieślicka, A., Trzepla, E., Członkowski, A., Filipiak, K., & Opolski, G. (2013) · Advances in Medical Sciences · doi:10.2478/ams-2013-0009 · Cited by 16
Wang, H., Gao, Y., Wu, Y., Li, C., & Duan, J. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.06.020 · Cited by 15
Yan, C., Li, S., Xiao, Q. F., Liu, Y., Hou, J., Chen, A., Xia, L., & Li, X. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.bqicc707 · Cited by 15
Cardiac hypertrophy in sarcopenic obese C57BL/6J mice is independent of Akt/mTOR cellular signaling
Perry, R. A., Brown, L. A., Haynie, W. S., Brown, J. L., Rosa‐Caldwell, M. E., Lee, D. E., Greene, N. P., & Washington, T. A. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.06.023 · Cited by 15
Impact of Either GLP-1 Agonists or DPP-4 Inhibitors on Pathophysiology of Heart Failure
Takahashi, A., Ihara, M., Yamazaki, S., Asanuma, H., Asakura, M., & Kitakaze, M. (2015) · International Heart Journal · doi:10.1536/ihj.15-028 · Cited by 14
Self-citationDifferences in AMPK expression between subcutaneous and visceral adipose tissue in morbid obesity
Martínez‐Augustin, O., Morante, J. J. H., Martínez-Plata, E., de Medina, F. S., & Garaulet, M. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.04.008 · Cited by 14
Adiponectin as a therapeutic target for obesity‐related metabolic and cardiovascular disorders
Wang, Y., Lam, K. S. L., & Xu, A. (2006) · Drug Development Research · doi:10.1002/ddr.20141 · Cited by 14
Liao, Y., Xuan, W., Zhao, J., Bin, J., Zhao, H., Asakura, M., Funahashi, T., Takashima, S., & Kitakaze, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.039 · Cited by 13
Self-citationOrphan receptor GPR37L1 contributes to the sexual dimorphism of central cardiovascular control
Coleman, J. L. J., Mouat, M. A., Wu, J., Jancovski, N., Bassi, J. K., Chan, A. Y., Humphreys, D. T., Mrad, N., Yu, Z., Ngo, T., et al. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0173-y · Cited by 12
Sun, C., Lu, J., Long, Y., Guo, S., Jia, W., Ning, N., Hao, H., Wang, X., Bian, Y., Liu, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16807 · Cited by 13
Du, Y., Zhang, S., Yu, H., Wu, Y., Cao, N., Wang, W., Xu, W., Li, Y., & Liu, H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010475 · Cited by 13
Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats
Wang, L.-L., Miller, D. J., Wanders, D., Nanayakkara, G., Amin, R., Judd, R. L., Morrison, E. E., & Zhong, J. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.84 · Cited by 11
Fusco‐Allison, G., Li, D. K., Hunter, B., Jackson, D., Bannon, P. G., Lal, S., & O’Sullivan, J. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13504 · Cited by 11
An Adiponectin-Like Molecule with Antidiabetic Properties
Sulpice, T., Prunet‐Marcassus, B., Molveaux, C., Cani, P. D., Vitte, P., Graber, P., Dréano, M., & Burcelin, R. (2009) · Endocrinology · doi:10.1210/en.2008-1768 · Cited by 11
Kang, M.-G., Lee, H. J., Cho, J., Kim, K., Yang, S. J., & Kim, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.102 · Cited by 11
Matsumoto, M., Lee‐Kawabata, M., Tsujino, T., Naito, Y., Ezumi, A., Sakoda, T., Ohyanagi, M., Shimomura, I., & Masuyama, T. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00368.x · Cited by 11
Self-citationHsu, C., Hsuan, C., Liao, D., Chang, J. K.-J., Chang, A. J.-W., Hee, S., Lee, H.-L., & Teng, S. I. F. (2023) · Life · doi:10.3390/life13041024 · Cited by 11
Potential interaction of brain natriuretic peptide with hyperadiponectinemia in preeclampsia
Masuyama, H., Nobumoto, E., Inoue, S., & Hiramatsu, Y. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00548.2011 · Cited by 10
Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7
Yang, H., Song, S., Li, J., Li, Y., Feng, J., Sun, Q. X., Qiu, X., Chen, Z., Bai, X., Liu, X., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04829-1 · Cited by 9
Nucleus‐localized adiponectin is survival gatekeeper through miR‐214‐mediated AIFM2 regulation
Cho, J., Teshigawara, R., Kameda, M., Yamaguchi, S., & Tada, T. (2018) · Genes to Cells · doi:10.1111/gtc.12658 · Cited by 9
Tarkhnishvili, A., Koentges, C., Pfeil, K., Gollmer, J., Byrne, N. J., Vosko, I., Lueg, J. C., Vogelbacher, L., Birkle, S., Tang, S., et al. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.161 · Cited by 9
Hasić, S., Hadžović-Džuvo, A., Jadrić, R., & Kiseljaković, E. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2329 · Cited by 9
The Cardioprotective Effects of Adiponectin in Diabetes
Kazemi, T., Mao, Y., & Zhang, T. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01610-5 · Cited by 8
Potential of Adiponectin as a Cardioprotective Agent
Shibata, R., Ouchi, N., Walsh, K. X., & Murohara, T. (2007) · Future Cardiology · doi:10.2217/14796678.3.6.647 · Cited by 8
Self-citationGarnier, A., Leroy, J., Deloménie, C., Matéo, P., Viollet, B., Veksler, V., Mericskay, M., Ventura‐Clapier, R., & Piquereau, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292015 · Cited by 8
Where is the Discovery in Literature-Based Discovery?
Kostoff, R. N. (2008) · Information science and knowledge management · doi:10.1007/978-3-540-68690-3_5 · Cited by 7
Kimura, K., Miura, S., Iwata, A., Sugihara, M., Arimura, T., Nishikawa, H., Kawamura, A., & Saku, K. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.08.012 · Cited by 7
Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease
Hoffelner, D. K., & Hendrikx, T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1631841 · Cited by 6
Plasma adiponectin concentration and left ventricular hypertrophy in kidney transplant patients
Adamczak, M., Błach, A., Kolonko, A., Szotowska, M., Chudek, J. T., Franek, E., & Więcek, A. (2010) · Clinical Transplantation · doi:10.1111/j.1399-0012.2010.01330.x · Cited by 6
Fawzi, H. A., Sabbar, R., Kadhim, S. A. A., Flayih, A., Mohammad, B. I., & Swadi, A. A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0253 · Cited by 7
Zhu, X., Chen, L.-H., & Li, J.-H. (2015) · Europe PMC (PubMed Central) · Cited by 6
Melaku, L. S., & Nebi, T. D. (2019) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_104_17 · Cited by 6
ADIPONECTIN AS A KEY PLAYER IN INFLAMMATION
Cheng, K. K. Y., Lam, K., Wang, Y., & Xu, A. (2006) · Biomedical Reviews · doi:10.14748/bmr.v17.79 · Cited by 6
Karmazyn, M., & Gan, X. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010003 · Cited by 5
Adiponectin deficiency has no effect in murine autoimmune myocarditis
Stroikova, V., Fischer, A., Bockstahler, M., Müller, A., Katus, H. A., & Kaya, Z. (2019) · Cytokine · doi:10.1016/j.cyto.2018.12.022 · Cited by 4
Adiponectin: A Multifunctional Adipokine
Clarke, K. J., & Judd, R. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_6 · Cited by 4
Vascular biology of adiponectin
Teoh, H., Szmitko, P. E., & Verma, S. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)71033-x · Cited by 4
Peer, M., Mashavi, M., Matas, Z., Harpaz, D., & Shargorodsky, M. (2014) · Angiology · doi:10.1177/0003319714523332 · Cited by 4
Xu, A., Wang, Y., & Lam, K. S. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-370-7_4 · Cited by 3
Bairwa, S. C., Rajapurohitam, V., Gan, X. T., Mangat, R., Proctor, S. D., & Karmazyn, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145992 · Cited by 3
Some Features of Correction of Adipose Tissue Dysfunction
Filiniuk, P. Y., Shishkin, A. N., Pchelin, I. Y., Khudyakova, N. V., Воловникова, В. А., & Кулибаба, Т. Г. (2023) · Juvenis scientia · doi:10.32415/jscientia_2023_9_6_6-17 · Cited by 3
The Role of AMPK in the Control of Cardiac Hypertrophy
Byrne, N. J., Sung, M. M. Y., & Dyck, J. R. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_13 · Cited by 3
The role of adipokines in the regulation of cardiovascular function
Karpushev, A. V., & Михайлова, В. Б. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-5-448-459 · Cited by 3
Lu, G., Tang, Y., Chen, O., Guo, Y., Xiao, M., Wang, J., Liu, Q., Li, J., Gao, T., Zhang, X., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.025 · Cited by 3
Cardioprotective Actions of Adiponectin
Ouchi, N., Shibata, R., & Walsh, K. X. (2007) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200714020-00003 · Cited by 1
Self-citationCardiovascular Research speeds up—Even more
Piper, H. M., Martinson, E. A., & Tobias Opthof, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.009 · Cited by 1
New Insights on Cardiomyopathy [Working Title]
Said, S. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100931 · Cited by 1
Malinova, L. I., Tolstov, S. N., Silina, T. S., Denisova, T. P., & Te, L. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2022-28-6-669-680 · Cited by 1
Metadata
- Authors
- LIAO, Y., TAKASHIMA, S., MAEDA, N., OUCHI, N., KOMAMURA, K., SHIMOMURA, I., HORI, M., MATSUZAWA, Y., FUNAHASHI, T., & KITAKAZE, M.
- Affiliations
- The University of Osaka (JP)
- National Cerebral and Cardiovascular Center (JP)
- Corresponding author
- KITAKAZE, M
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 67
- Issue
- 4
- Pages
- 705-713
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2148710672
- Cited by
- 236
- References
- 48
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 8 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 13 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 13 · 2013: 10 · 2012: 16
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- adiponectin, heart failure, AMPK, AMPKα, insulin resistance, glucose metabolism, cardiac hypertrophy, pressure overload, transverse aortic constriction, cardiac remodeling, adiponectin knockout mice, pulmonary congestion
- MeSH terms
- Adenylate Kinase, Animals, Blood Glucose, Echocardiography, Fasting, Heart Failure, Insulin, Insulin Resistance, Male, Myocardium, Blotting, Western, Mice, Knockout, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review